SS
ADPT icon

SBI Securities’s Adaptive Biotechnologies ADPT Stock Holding History

SBI Securities’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7K Buy
126
+35
+38% +$536 ﹤0.01% 2450
2026
Q1 		$1.26K Buy
91
+40
+78% +$637 ﹤0.01% 2566
2025
Q4 		$828 Sell
51
-317
-86% -$5.17K ﹤0.01% 2708
2025
Q3 		$5.5K Buy
368
+82
+29% +$999 ﹤0.01% 2001
2025
Q2 		$3.33K Hold
286
– – ﹤0.01% 2175
2025
Q1 		$2.13K Hold
286
– – ﹤0.01% 2265
2024
Q4 		$1.72K Buy
+286
New +$1.58K ﹤0.01% 2367

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SBI Securities's ADPT Position: Q2 2026 in Review

SBI Securities increased its Adaptive Biotechnologies (ADPT) stake by 38% in Q2 2026, buying an estimated $536 and bringing the position to 126 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2450.

SBI Securities first reported a position in ADPT in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.5K in Q3 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • SBI Securities held 126 shares of Adaptive Biotechnologies worth $2.7K as of Q2 2026.
  • SBI Securities bought 35 Adaptive Biotechnologies shares in Q2 2026, an estimated $536.
  • Adaptive Biotechnologies made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2450 holding.
  • SBI Securities first reported a position in Adaptive Biotechnologies in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Adaptive Biotechnologies position peaked at $5.5K in Q3 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.